REGENERATIVE TREATMENTS MADE EASY

OUR MISSION

Providing effective regenerative solutions for a sustainable healthcare

THE PROBLEM

Healthcare providers spend big money for treating chronic diseases.

THE SOLUTION

There is a strong scientific background for bedside Regenerative Treatments and they are considered an excellent treatment option for faster and better clinical results in various specialties like: Orthobiologics, Plastic Surgery, General Surgery, Chronic Wounds, Burns and Diabetic Foot.

slider-1-1

THE SCIENCE BEHIND MyStem®

PARTNERS

UMCG
ICRS
IFATS
MOH India
PRS
SFDA

STROMAL TISSUE (ST), A REGENERATIVE SOURCE

picture1
picture2

There is a worldwide consensus that the isolation and collection of regenerative Mesenchymal Stem Cells (MSC’s) from differentiated body tissues is the most ethical option available today in Regenerative Medicine.

Furthermore, among the tissues where MSC’s are available for collection is clear that Stromal Tissue (ST) surrounding Adipose structures is the best source of readily available MSC’s.

This global preference is due to the following factors:- ST is easy to access and harvest – ST is available in adequate quantities in the body – ST has a very large density of Regenerative Cells (10-100 fold more stem cells than other body tissues).

The myStem® device collects this regenerative fraction without extensive manipulation in a completely safe closed sterile system and in accordance with international regulations.

The regenerative fraction separation process is based on the intrinsic parameters of cells in a liquid fraction according to fluidic laws. After the simple one step separation process is completed the concentrated Regenerative suspension is ready for use. Additionally the suspension can be further concentrated  using a proprietary technology.

This innovative device is based on GMP-proof non-enzymatic tissue separation and cellular enrichment, enabling a rapid (10-15 minute) isolation from human stromal tissues in a closed sterile system.We benchmarked our technology with: standard protocol (PLA), lipoaspirate fluid protocol (LAF) and myStem® protocol.

Our offices

EMEA Branch:

MyStem Limited,

Kithiron 3,  2103 Aglantia, Cyprus

Headquarter

MyStem LLC,

2701 Centerville Rd., 19808 Wilmington, United States

CONTACT US


LOCATION